Advertisement
Screener

CANNAPHARMARX, INC. (CPMD) Increase (Decrease) in Other Accounts Payable and Accrued Liabilities

2.8 / 5 stars · 68/120 Roast Me

CANNAPHARMARX, INC. Increase (Decrease) in Other Accounts Payable and Accrued Liabilities

CANNAPHARMARX, INC. (CPMD) reported Increase (Decrease) in Other Accounts Payable and Accrued Liabilities of $703.46 thousand for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-20.

Financial Statements › Cash Flow › Operating Activities

us-gaap:IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities · last filed 2026-05-20

  • CANNAPHARMARX, INC. increase (decrease) in other accounts payable and accrued liabilities for the quarter ending 2026-03-31 was $703.46K, a 250.92% increase year-over-year.
  • CANNAPHARMARX, INC. increase (decrease) in other accounts payable and accrued liabilities for the quarter ending 2025-06-30 was $270.94K, a 35.87% increase year-over-year.
  • CANNAPHARMARX, INC. increase (decrease) in other accounts payable and accrued liabilities for the quarter ending 2025-03-31 was $200.46K.
  • CANNAPHARMARX, INC. increase (decrease) in other accounts payable and accrued liabilities for the quarter ending 2024-06-30 was $199.41K.
  • CANNAPHARMARX, INC. increase (decrease) in other accounts payable and accrued liabilities for fiscal 2025 was $2.88M, a 276.90% increase from fiscal 2024.
  • CANNAPHARMARX, INC. increase (decrease) in other accounts payable and accrued liabilities for fiscal 2024 was $763.57K.
Period endIncrease (Decrease) in Other Accounts Payable and Accrued Liabilities 3 monthIncrease (Decrease) in Other Accounts Payable and Accrued Liabilities 6 monthIncrease (Decrease) in Other Accounts Payable and Accrued Liabilities 12 month
2026-03-31$703.46K
10-Q · filed 2026-05-20
2025-12-31$2.88M
10-K · filed 2026-03-31
2025-06-30$270.94K
10-Q · filed 2025-08-14
$532.23K
10-Q · filed 2025-08-14
2025-03-31$200.46K
10-Q · filed 2026-05-20
2024-12-31$763.57K
10-K · filed 2026-03-31
2024-06-30$199.41K
10-Q · filed 2025-08-14
$398.83K
10-Q · filed 2025-08-14